GYGES
Live / Allowed — Third extension granted (statement of use) (as of 09 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jul 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98104136
- Mark type
- Word mark
- Filed
- 27 Jul 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Maria Maebius
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Owner
- C-Reveal Therapeutics LLC, Bethesda, MD, US
- C-Reveal Therapeutics LLC, Bethesda, MD, US
Prosecution history
- 13 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2026 — SOU EXTENSION 3 GRANTED
- 01 Jan 2026 — SOU EXTENSION 3 FILED
- 02 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 02 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 02 Feb 2026 — PETITION TO REVIVE-GRANTED
- 02 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 2 GRANTED
- 01 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 15 Jul 2025 — NOTICE OF REVIVAL - E-MAILED